BlackRock’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
BlackRock's ELV Position: Q2 2026 in Review
BlackRock reduced its Elevance Health (ELV) stake by 4.5% in Q2 2026, selling an estimated $332M and leaving 18,991,090 shares worth $7.34B. The position accounts for 0.11% of the portfolio, ranked #141.
BlackRock first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.2B in Q2 2024. 1,608 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- BlackRock held 18,991,090 shares of Elevance Health worth $7.34B as of Q2 2026.
- BlackRock sold 896,021 Elevance Health shares in Q2 2026, an estimated $332M.
- Elevance Health made up 0.11% of BlackRock's portfolio in Q2 2026, its #141 holding.
- BlackRock first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Elevance Health position peaked at $11.2B in Q2 2024.
- 1,608 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.